Zimvie INC 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

ZimVie Inc. has entered into a definitive agreement to be acquired by an affiliate of ARCHIMED for $19.00 per share in cash, representing a 99% premium, while reporting improved operating profit and reduced net loss for the second quarter and first half of 2025.
ZimVie Inc. reports a net loss of $1.471 million for Q1 2025, impacted by decreased sales and restructuring activities following the sale of its spine segment, while focusing on its dental business.
ZimVie Inc. reports a net loss of $2.284 million for the third quarter of 2024, following the sale of its spine segment.
ZimVie Inc. reports a net loss for the second quarter of 2024, impacted by the recent sale of its spine business, while focusing on its core dental operations.
ZimVie Inc. reports a net loss of $7.76 million for the first quarter of 2024, impacted by the divestiture of its spine business and restructuring activities.